Complex cellular responses involving changes in the actin cytoskeleton, cell shape and migration involve the integration of signal transduction pathways regulated by seven transmembrane receptor (STMR) heterotrimeric G proteins and tyrosine kinases. A convergence point for the integration of STMR/G protein and tyrosine kinase signaling is the control of low molecular weight GTP binding proteins including Ras and Rho family members (Rho, Rac,Cdc42). Characterization of STMR/G protein integration with tyrosine kinases and Ras/Rho GTP binding proteins will be defined in two systems: i. chemokine receptor signaling in the neutrophil, and ii. gastrin releasing peptide (GRP) receptor regulation of Gq and G1213 signaling in fibroblasts. Neutrophils are a primary source of tissue injury at inflammatory sites in diseases includingrespiratory distress syndrome and inflammatory bowel disease. Neutrophils migrate to an inflammatory site in response to chemokines such as IL8. The IL8 receptor and other chemokine receptors are STMR coupled to G proteins which in response to chemokine rapidly activate the tyrosine kinases Lyn, Fgr, Hck and Syk. We shall define the requirement of these kinases in neutrophil responses to chemokines using neutrophils isolated from mice having the triple targeted disruption of the Lyn, Fgr and Hck genes (Lyn^/Fgr^'/Hck""""""""'"""""""") and the Syk gene (Syk""""""""'""""""""). The targeted disruption of the primary Src kinases (Lyn, Fgr, Hck) expressed in neutrophils and Syk will allow for the first time to define the involvement of these kinases in chemokine activation of the neutrophil and their role in chemokine stimulated inflammatory responses. Neuropeptides including GRP function in neuron-to-neuron communication, signaling in the immune system, epithelial cell proliferation and tissue restructuring. The GRP receptor is a STMR coupling to the G proteins G n and G1213. Peptide ligands have been characterized that activate the GRP receptor so that only G1213 and not G ,, are activated. The peptide ligands function as """"""""biased agonists"""""""" that induce """"""""asymmetric signaling"""""""". G1213 regulates the c-Jun kinase pathway and Rho family GTP binding proteins. Biased agonists provide a mechanism for the selective control of G protein signaling by STMRs. The amino acids in the GRPR primary sequence that are required for biased signaling will be defined. The consequence of biased agonism on cell growth, gene expression and regulation of the actin cytoskeleton will be defined. Cumulatively, the studies will define new strategies for the development of pharmacological ligandsto regulate subsets of receptor functions that will have much more selective effects on target cells and tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM030324-29
Application #
7141697
Study Section
Special Emphasis Panel (NSS)
Program Officer
Anderson, Richard A
Project Start
1988-09-01
Project End
2008-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
29
Fiscal Year
2007
Total Cost
$422,871
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pharmacology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Zawistowski, Jon S; Nakamura, Kazuhiro; Parker, Joel S et al. (2013) MicroRNA 9-3p targets ?1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition. Mol Cell Biol 33:2260-74
Duncan, James S; Whittle, Martin C; Nakamura, Kazuhiro et al. (2012) Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 149:307-21
Cronan, M R; Nakamura, K; Johnson, N L et al. (2012) Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene 31:3889-900
Huang, Weichun; Umbach, David M; Vincent Jordan, Nicole et al. (2011) Efficiently identifying genome-wide changes with next-generation sequencing data. Nucleic Acids Res 39:e130
Abell, Amy N; Jordan, Nicole Vincent; Huang, Weichun et al. (2011) MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell 8:525-37
Jordan, Nicole Vincent; Johnson, Gary L; Abell, Amy N (2011) Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 10:2865-73
Nakamura, Kazuhiro; Kimple, Adam J; Siderovski, David P et al. (2010) PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem 285:2077-89
Konhilas, John P; Boucek, Dana M; Horn, Todd R et al. (2010) The role of MEKK1 in hypertrophic cardiomyopathy. Int Heart J 51:277-84
Nakamura, Kazuhiro; Johnson, Gary L (2010) Activity assays for extracellular signal-regulated kinase 5. Methods Mol Biol 661:91-106
Abell, Amy N; Granger, Deborah A; Johnson, Nancy L et al. (2009) Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase. Mol Cell Biol 29:2748-61

Showing the most recent 10 out of 11 publications